Skull Base Involvement by Acinic Cell Carcinoma of the Parotid Gland

Abstract

Objective Describe the clinical course and outcomes of patients with primary acinic cell carcinoma (ACC) of the parotid gland with skull base invasion or metastasis.

Design Retrospective case series (1995–2011) at a single institution.

Results Ten patients met study criteria. Mean and median time from initial diagnosis of parotid ACC to development of skull base disease were 14.6 and 10.2 years, respectively. Two patients demonstrated skull base disease on initial presentation. Those who pursued further treatment after developing disease at the skull base underwent surgery (4/7), stereotactic radiosurgery (4/7), or external beam radiation (3/7). The 10-year Kaplan-Meier estimated overall survival after initial diagnosis of parotid ACC was 80%. Once skull base invasion occurred, 2-year estimated overall survival was 50%.

Conclusion Although primary ACC of the parotid generally caries an excellent prognosis, tumor control with cranial base disease is difficult and the majority of patients present with late aggressive recurrences. Our observations underscore the importance of long-term follow-up in this patient group.

Keywords

acinic cell carcinoma - salivary tumors - skull base - cranial base

• References

• 1 Hoffman HT, Karnell LH, Robinson RA, Pinkston JA, Menck HR. National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck 1999; 21: 297-309
• 2 Spafford PD, Mintz DR, Hay J. Acinic cell carcinoma of the parotid gland: review and management. J Otolaryngol 1991; 20: 262-266
• 3 Leonetti JP, Marzo SJ, Agarwal N. Adenoid cystic carcinoma of the parotid gland with temporal bone invasion. Otol Neurotol 2008; 29: 545-548
• 4 Martinez-Devesa P, Barnes ML, Milford CA. Malignant tumors of the ear and temporal bone: a study of 27 patients and review of their management. Skull Base 2008; 18: 1-8
• 5 Vidyadhara S, Shetty AP, Rajasekaran S. Widespread metastases from acinic cell carcinoma of parotid gland. Singapore Med J 2007; 48: e13-e15
• 6 Kim SA, Mathog RH. Acinic cell carcinoma of the parotid gland: a 15-year review limited to a single surgeon at a single institution. Ear Nose Throat J 2005; 84: 597-602
• 7 Prasad M, Kraus DH. Acinic cell carcinoma of the parotid gland presenting as an external auditory canal mass. Head Neck 2004; 26: 85-88
• 8 Kinney SE, Wood BG. Malignancies of the external ear canal and temporal bone: surgical techniques and results. Laryngoscope 1987; 97: 158-164
• 9 Lewis JE, Olsen KD, Weiland LH. Acinic cell carcinoma. Clinicopathologic review. Cancer 1991; 67: 172-179
• 10 Gomez DR, Katabi N, Zhung J , et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer 2009; 115: 2128-2137
• 11 Douglas JG, Goodkin R, Laramore GE. Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy. Head Neck 2008; 30: 492-496
• 12 Ellis GL, Corio RL. Acinic cell adenocarcinoma. A clinicopathologic analysis of 294 cases. Cancer 1983; 52: 542-549
• 13 Perzin KH, LiVolsi VA. Acinic cell carcinomas arising in salivary glands: a clinicopathologic study. Cancer 1979; 44: 1434-1457
• 14 Levin JM, Robinson DW, Lin F. Acinic cell carcinoma: collective review, including bilateral cases. Arch Surg 1975; 110: 64-68
• 15 Batsakis JG, Luna MA, el-Naggar AK. Histopathologic grading of salivary gland neoplasms: II. Acinic cell carcinomas. Ann Otol Rhinol Laryngol 1990; 99: 929-933
• 16 Federspil PA, Constantinidis J, Karapantzos I, Pahl S, Markmann HU, Iro H. [Acinic cell carcinomas of the parotid gland. A retrospective analysis]. HNO 2001; 49: 825-830